Skip to main content

Genprex, Inc.

GNPX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595248

No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Genprex, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of GNPX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders3617−19
SharesConverted for a 1-for-40 split126.0K143.1K+17.1K (+13.6%)
Value$1.16M$426.0K−$733.6K (−63.3%)

New holders (3)

Institutions that held Genprex, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to GNPX in Q1 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC97,868$291.6K0.01%
Nemes Rush Group LLC250$7450.00%
Sofos Investments, Inc.21$620.00%

Sold out (22)

Institutions that held Genprex, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.